Incorporating biological information in quantitative risk assessment: an example with methylene chloride.

The interplay between chemical risk assessment and scientific research is discussed in the context of recent attempts to improve the scientific basis for estimates of the human carcinogenic risk from methylene chloride. A combination of basic biochemical research and risk assessment oriented research, both mechanistic and pharmacokinetic, provided the initial impetus for re-evaluating the use of the default risk estimation approach. Resulting efforts to incorporate the new scientific information into the risk assessment process in turn identified specific additional research needed to reduce uncertainty in the estimated risk. This healthy interchange between the two disciplines has served both to refine the human risk estimates for methylene chloride and to more clearly identify key scientific issues for chemical risk assessment in general.

[1]  M. W. Anders,et al.  Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[2]  Richard D. Thomas.  Drinking Water and Health , 1986 .

[3]  H J Clewell,et al.  Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. , 1991, Toxicology and applied pharmacology.

[4]  B. Allen,et al.  Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output. , 1989, Toxicology letters.

[5]  A. Wilson,et al.  Human Risk Assessment—The Role of Animal Selection and Extrapolation , 1987 .

[6]  Dale Hattis,et al.  Improvements in Quantitative Noncancer Risk Assessment , 1993 .

[7]  J. N. Blancato,et al.  Update to the health assessment document and addendum for dichloromethane (methylene chloride): pharmacokinetics, mechanism of action, and epidemiology. External review draft , 1987 .

[8]  C J Portier,et al.  Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[9]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[10]  M. Andersen,et al.  Gas uptake studies of deuterium isotope effects on dichloromethane metabolism in female B6C3F1 mice in vivo. , 1994, Toxicology and applied pharmacology.

[11]  R H Reitz,et al.  In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.

[12]  R. Coulombe,et al.  Pharmacokinetics in Risk Assessment , 1996 .

[13]  B C Allen,et al.  Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[14]  H J Clewell,et al.  Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. , 1986, Toxicology and applied pharmacology.

[15]  Crump Ks,et al.  An improved procedure for low-dose carcinogenic risk assessment from animal data. , 1984 .

[16]  L. Dipasquale,et al.  Perinatal toxicology of mirex administered in the diet: II. Relationship of hepatic mirex levels to induction of microsomal benzphetamine N-demethylase activity , 1979 .

[17]  D. Wolf,et al.  Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice , 1993 .

[18]  H J Clewell,et al.  Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[19]  H J Clewell,et al.  Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing. , 1993, Toxicology letters.

[20]  M L Dourson,et al.  Improvements in quantitative noncancer risk assessment. Sponsored by the Risk Assessment Specialty Section of the Society of Toxicology. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[21]  M. W. Anders,et al.  Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[22]  M. McKenna,et al.  The pharmacokinetics of inhaled methylene chloride in rats. , 1982, Toxicology and applied pharmacology.

[23]  K S Crump,et al.  Correlation between carcinogenic potency of chemicals in animals and humans. , 1988, Risk Analysis.

[24]  M L Gargas,et al.  Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. , 1993, Toxicology and applied pharmacology.

[25]  Stephen S. Olin,et al.  Low-dose extrapolation of cancer risks : issues and perspectives , 1995 .

[26]  M. McKenna,et al.  Pulmonary physiology and inhalation dosimetry in rats: development of a method and two examples. , 1983, Toxicology and applied pharmacology.

[27]  M. Hegi,et al.  Hepatic and pulmonary carcinogenicity of methylene chloride in mice: a search for mechanisms. , 1995, Toxicology.